NCT02682667
- Conditions
- Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +31 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Leukemia, T-Cell
Explore clinical trials studying Leukemia, T-Cell. Study availability and eligibility vary by location and protocol.
144 public trials
25 recruiting studies
Leukemia, T-Cell trial results
NCT05010005
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
- Locations
-
- University of Miami (Data Collection Only) Miami, Florida, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
NCT01676805
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- University of the West Indies Kingston, Jamaica
NCT03719105
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Children's Hospital Orange County Orange, California, United States
- University of California San Francisco San Francisco, California, United States
- Helen De Vos Grand Rapids, Michigan, United States
Recruiting
Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases
NCT07727083
- Conditions
- Aggressive NK-cell Leukemia, DNA Virus Infections, Epstein-Barr Virus Infections, +24 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT07311746
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
Recruiting
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
NCT06810778
- Conditions
- Cutaneous T-Cell Lymphoma Refractory, Disease Attributes, Hematologic Diseases, +16 more
- Locations
-
- David Geffen School of Medicine at the University of California at Los Angeles Los Angeles, California, United States
Recruiting
Registry of Older Patients With Cancer
NCT01137825
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
- Locations
-
- Seby B. Jones Cancer Center Boone, North Carolina, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
- East Carolina University Greenville, North Carolina, United States
- Pardee Cancer Center Hendersonville, North Carolina, United States
Recruiting
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
NCT05475925
- Conditions
- Aggressive NK Cell Leukemia, Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), +27 more
- Locations
-
- Dren Investigational Site Birmingham, Alabama, United States
- Dren Investigational Site Duarte, California, United States
- Dren Investigational Site Irvine, California, United States
- Dren Investigational Site Redwood City, California, United States
Recruiting
Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection
NCT07555431
- Conditions
- Central Nervous System Diseases, Central Nervous System Infections, Deltaretrovirus Infections, +29 more
- Locations
-
- Hospital Universitário Professor Edgard Santos Salvador, Estado de Bahia, Brazil